# Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

> **NCT00985036** · — · WITHDRAWN · sponsor: **Marquette General Health System**

## Conditions studied

- Glioma
- Meningioma

## Interventions

- **PROCEDURE:** Blood test

## Key facts

- **NCT ID:** NCT00985036
- **Lead sponsor:** Marquette General Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09
- **Primary completion:** 2011-09
- **Final completion:** 2012-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00985036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00985036, "Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00985036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*